Holders over time
- CHE
- CI
| Quarter | CHE | CI |
|---|---|---|
| Q3 2020 | 16 holders, $1.0bn | 34 holders, $18.1bn |
| Q4 2020 | 14 holders, $1.1bn | 22 holders, $21.9bn |
| Q1 2021 | 13 holders, $898m | 24 holders, $23.9bn |
| Q2 2021 | 13 holders, $920m | 31 holders, $22.5bn |
| Q3 2021 | 13 holders, $1.0bn | 30 holders, $17.8bn |
| Q4 2021 | 13 holders, $1.1bn | 26 holders, $20.1bn |
| Q1 2022 | 12 holders, $906m | 28 holders, $20.4bn |
| Q2 2022 | 12 holders, $798m | 32 holders, $22.1bn |
| Q3 2022 | 12 holders, $664m | 31 holders, $21.5bn |
| Q4 2022 | 13 holders, $834m | 30 holders, $24.7bn |
| Q1 2023 | 13 holders, $855m | 35 holders, $18.2bn |
| Q2 2023 | 13 holders, $961m | 30 holders, $19.8bn |
| Q3 2023 | 16 holders, $982m | 28 holders, $19.8bn |
| Q4 2023 | 13 holders, $1.1bn | 31 holders, $20.6bn |
| Q1 2024 | 12 holders, $1.1bn | 28 holders, $24.0bn |
| Q2 2024 | 14 holders, $912m | 28 holders, $19.5bn |
| Q3 2024 | 13 holders, $693m | 25 holders, $20.2bn |
| Q4 2024 | 11 holders, $588m | 23 holders, $15.2bn |
| Q1 2025 | 12 holders, $657m | 24 holders, $18.4bn |
| Q2 2025 | 11 holders, $582m | 34 holders, $19.5bn |
| Q3 2025 | 8 holders, $487m | 28 holders, $16.2bn |
| Q4 2025 | 13 holders, $634m | 21 holders, $14.6bn |
| Q1 2026 | 12 holders, $612m | 26 holders, $13.5bn |
| Q2 2026 | 10 holders, $807m | 28 holders, $13.0bn |
Chemed Corp New
- Holders
- 13
- Reported value
- $634m
- Buyers
- 17
- Sellers
- 15
Breadth +2 among 92 comparable managers.
The Cigna Group
- Holders
- 21
- Reported value
- $14.6bn
- Buyers
- 20
- Sellers
- 23
Breadth -3 among 92 comparable managers.
Who holds both, Q4 2025
Both (9)
Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, GAMCO Investors Inc, Man Group PLC, Moore Capital Management LP, Neuberger Berman Group LLC, Quantbot Technologies LP, Two Sigma Advisers LP
Only CHE (4)
Brevan Howard Capital Management LP, Caxton Associates LLP, Two Sigma Investments LP, Voloridge Investment Management LLC
Only CI (12)
Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Glenview Capital Management LLC, Greenlight Capital, Invesco Ltd, MFS Investment Management, Squarepoint Ops LLC, T. Rowe Price Associates Inc
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.